AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fresenius Medical Care AG & Co. KGaA

Transaction in Own Shares Jun 24, 2019

165_rns_2019-06-24_f70ad0f8-605a-4870-8f23-8341850c1e60.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

News Details

Other Capital Market Information | 24 June 2019 17:35

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Fresenius Medical Care AG & Co. KGaA
/ Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation
(EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052

24.06.2019 / 17:35
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


  • Share buy-back - 1st Interim Report

In the period from June 17, 2019 until and including June 21, 2019, a total
of 268,881 shares were repurchased within the framework of the share buy-
back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical
Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of
Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU)
2016/1052.

The purchase was carried out exclusively by a credit institution
commissioned by Fresenius Medical Care via the XETRA trading platform on
the Frankfurt Stock Exchange:

Day of repurchase Aggregated volume in Weighted average share
number of shares price
in EUR
17.06.2019 59,935 67.2681
18.06.2019 91,593 67.8108
19.06.2019 34,675 69.7601
20.06.2019 37,074 71.3736
21.06.2019 45,604 70.8628

The total volume of shares repurchased within the framework of this share
buy-back in the period from June 17, 2019 until and including June 21, 2019
therefore amounts to 268,881 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical
Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., June 24, 2019


24.06.2019 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de


 Language:    English
 Company:     Fresenius Medical Care AG & Co. KGaA
              Else-Kröner-Straße 1
              61352 Bad Homburg
              Germany
 Internet:    www.freseniusmedicalcare.com



 End of News    DGAP News Service

Talk to a Data Expert

Have a question? We'll get back to you promptly.